Measles-containing-vaccine second-dose (MCV2) immunization coverage in Naoero
Naoero: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 51.0% in 2025. ▲ Rising
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Naoero, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Naoero stood at 51.0%.
The figure is down 1.9% on the previous year and down 46.9% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Naoero peaked at 99.0% in 2007 and was at its lowest, 0.0%, in 2000.
That places Naoero 173rd out of 194 countries with data for 2025, putting it in the bottom quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Naoero, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 95.0% | — |
| 2002 | 83.0% | -12.6% |
| 2003 | 72.0% | -13.3% |
| 2004 | 60.0% | -16.7% |
| 2005 | 50.0% | -16.7% |
| 2006 | 97.0% | +94.0% |
| 2007 | 99.0% | +2.1% |
| 2008 | 99.0% | +0.0% |
| 2009 | 92.0% | -7.1% |
| 2010 | 99.0% | +7.6% |
| 2011 | 99.0% | +0.0% |
| 2012 | 81.0% | -18.2% |
| 2013 | 88.0% | +8.6% |
| 2014 | 94.0% | +6.8% |
| 2015 | 96.0% | +2.1% |
| 2016 | 97.0% | +1.0% |
| 2017 | 94.0% | -3.1% |
| 2018 | 94.0% | +0.0% |
| 2019 | 95.0% | +1.1% |
| 2020 | 97.0% | +2.1% |
| 2021 | 99.0% | +2.1% |
| 2022 | 99.0% | +0.0% |
| 2023 | 76.0% | -23.2% |
| 2024 | 52.0% | -31.6% |
| 2025 | 51.0% | -1.9% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 74.7% | 0.0% | 99.0% | 10 |
| 2010s | 93.7% | 81.0% | 99.0% | 10 |
| 2020s | 79.0% | 51.0% | 99.0% | 6 |
Countries ranked near Naoero
- 170 Equatorial Guinea 53.0% compare
- 171 Mali 52.0% compare
- 171 Chad 52.0% compare
- 173 Congo, Democratic Republic of the 51.0% compare
- 175 Côte d'Ivoire 49.0% compare
- 176 Haiti 48.0% compare
More health data for Naoero
- Heat deaths vs projected death rates, annual growth rate 0.8477 % change on previous year (2090)
- Heat deaths vs projected death rates 1,118 (2090)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Un projection of annual infant deaths 2 (2100)
- Age population, age 07, female, interpolated 137 (2025)
- Age population, age 09, male, interpolated 160 (2025)
- Age population, age 09, female, interpolated 147 (2025)
- Age population, age 08, male, interpolated 157 (2025)
- Age population, age 08, female, interpolated 141 (2025)
- Age population, age 07, male, interpolated 149 (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Naoero?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Naoero was 51.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Naoero?
- The highest recorded value was 99.0% in 2007.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Naoero?
- The lowest recorded value was 0.0% in 2000.
- How does Naoero rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Naoero ranks 173rd out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Naoero?
- Over the last ten years it is down 46.9%. The long-run trend across the full record is rising.
- Where does this Naoero data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).